Fujisawa Pharmaceutical Company Limited

Antibiotics Veterinary

Contact Details: 2-10 Nihonbashi Hon-cho 2-chome Chuo-ku Tokyo Tokyo 103 Japan Tel: 81 3 3279 0871 Fax: 81 3 3241 0722 Email: WWW: www.fujisawa.co.jp/

Recent Publications by Fujisawa Pharmaceutical Company Limited:
Structural basis of compound recognition by adenosine deaminase. Structural snapshots corresponding to various states enable elucidation of...	22nd December, 2005	Exploratory Research Laboratories, Fujisawa Pharmaceutical Company, Ltd.,	Biochemistry. 2005 Aug 9;44(31):10562-9. DOI Direct Link
Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice. We performed a scanning and transmission electron microscopic study on the...	15th November, 2005	Department of Infectious Diseases, Medicinal Biology Research	Med Mycol. 2005 Aug;43(5):439-45.
Effect of structural relaxation on the physical and aerosol properties of amorphous form of FK888 (NK1 antagonist). FK888 (NK1 antagonist) is a candidate drug for migraine and selected as a...	30th August, 2005	Analytical Research Laboratories, Fujisawa Pharmaceutical Company, Ltd.,	Chem Pharm Bull (Tokyo). 2005 May;53(5):498-502.
Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig. The antiplatelet and antithrombotic effects of FR171113,...	13th July, 2004	Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Company,	Eur J Pharmacol. 2003 Jul 25;473(2-3):163-9.
Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents. Despite several decades of progress, bone-specific delivery is still...	13th May, 2004	Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa	Clin Pharmacokinet. 2003;42(15):1319-30.
→View more Fujisawa Pharmaceutical Company Limited research publications.

BioNews Results for Fujisawa Pharmaceutical Company Limited:
SuppreMol Announces Expansion of its Management Team and Board Changes	Pharma Live:  Oct 21 2008 6:54PM Matching: fujisawa pharmaceutical company

Fujisawa Pharmaceutical Company Limited Patents:
US Patent No.	Title
4931453	Di phenylpyridazine compounds, processes for the preparation thereof and pharmaceutical compositions comprising the same
4983596	3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid derivatives and their preparation
5009713	Cement composition and a process for preparation thereof
5017703	Indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
5019500	IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof
→View more Fujisawa Pharmaceutical Company Limited patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 16 individuals from Fujisawa Pharmaceutical Company Limited using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 204 times since April 2007, the link to the organisation's website has been followed 32 times

Recent Search Terms used to find this page: fujisawa pharmaceutical company ltd | fujisawa pharm | Fujisawa Pharmaceutical Company | Fujisawa Pharmaceutical Company | Medicinal Biology Research Laboratories Fujisawa Pharmaceutical | FK888 astellas | t | Bone-Specific Drug Delivery Systems | Bone-Specific Drug Delivery Systems | .

Search for more companies in Tokyo

Search for more companies in Tokyo

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Fujisawa Pharmaceutical Company Limited